Wixela Inhub Powder
Product Images NDC 0378-9322
Product Visual Gallery
This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Wixela Inhub (NDC 0378-9322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Salmeterol Zinofoate Structural Formula (Image 03)
Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Image 04)
Figure 2. Percent Change In Serial 12-hour Fev1 In Subjects With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Image 05)
Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Image 06)
Figure 4. Predose Fev1: Mean Percent Change From Baseline In Subjects With Chronic Obstructive Pulmonary Disease (Image 07)
Figure 5. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Subjects With Chronic Obstructive Pulmonary Disease (Image 08)
Instructions For Use Figure A (Image 01)
Instructions For Use Figure B (Image 09)
Instructions For Use Figure C (Image 10)
Instructions For Use Figure D (Image 11)
Instructions For Use Figures E And F (Image 12)
Instructions For Use Figure G (Image 13)
Instructions For Use Figure H (Image 14)
Instructions For Use Refill Image 01 (Image 15)
Instructions For Use Refill Image 02 (Image 16)
Instructions For Use Refill Image 03 (Image 17)
Wixela Principal Display Panel Figure 01 (Image 18)
Wixela Principal Display Panel Figure 02 (Image 19)
Wixela Principal Display Panel Figure 03 (Image 20)
Wixela Principal Display Panel Figure 04 (Image 21)
Wixela Principal Display Panel Figure 05 (Image 22)
Wixela Inhalation Powder 100/50 Carton Label (Image 23)
Wixela Principal Display Panel Figure 01 (Image 24)
Wixela Principal Display Panel Figure 02 (Image 25)
Wixela Principal Display Panel Figure 03 (Image 26)
Wixela Principal Display Panel Figure 04 (Image 27)
Wixela Principal Display Panel Figure 05 (Image 28)
Wixela Inhalation Powder 250/50 Carton Label (Image 29)
Wixela Principal Display Panel Figure 01 (Image 30)
Wixela Principal Display Panel Figure 02 (Image 31)
Wixela Principal Display Panel Figure 03 (Image 32)
Wixela Principal Display Panel Figure 04 (Image 33)
Wixela Principal Display Panel Figure 05 (Image 34)
Wixela Inhalation Powder 500/50 Carton Label (Image 35)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.